Previous Close | 82.94 |
Open | N/A |
Bid | 68.15 |
Ask | 74.00 |
Strike | 220.00 |
Expire Date | 2024-07-19 |
Day's Range | 82.94 - 82.94 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Moderna stock skidded Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024 Agency has indicated it expects to complete the review by end of May CAMBRIDGE, MA / ACCESSWIRE ...